ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 72

The Presence of IgM Rheumatoid Factor Impede Immunodetection of Tnfa on Circulating Extracellular Vesicles Obtained from Rheumatoid Arthritis Patients

Onno J. Arntz1, Bartijn C.H. Pieters1, Rogier Thurlings2, Peter M. van der Kraan3, F van den Hoogen2 and Fons A.J. van de Loo3, 1Experimental Rheumatology, Radboudumc, Nijmegen, Netherlands, 2Rheumatology, Radboudumc, Nijmegen, Netherlands, 3Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: cytokines and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis Poster I: The Variable World of Intercellular Signalling

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Tumor-necrosis factor (TNF)-α plays a key role in the pathophysiology of rheumatoid arthritis (RA) and membrane bound TNFα is sufficient to induce arthritis in mice [1]. Zhang [2] demonstrated membrane bound TNFα on extracellular vesicles (EVs) derived from RA synovial fibroblasts. EVs are stable in body fluids and mediate intercellular communication over short and long distances. In this study we want to determine whether TNFα is also present on circulating EVs from RA patients and not in healthy individuals.

Methods: pEVs were obtained from 28 RA patients and 24 healthy controls (HC) by size exclusion chromatography. Protein content was measured by micro-BCA, size and concentration by Nanoparticle Tracking. TNFα was detected by bead-based multiplex immunoassays (BBI) and flowcytometry (FC). To control for specificity, pEVs were preincubated with anti-TNFα (etanercept and certolizumab pegol). Immunoglobulin M rheumatoid factor (IgM-RF) was measured in pEVs by ELISA. RF+ and RF- pEVs were preincubated with Protein L beads to bind RF-IgM before TNFα was measured by FC.

Results: Particle size and protein content per particle were significantly higher in RA-pEVs as compared to HC (154nm, 484fg and 116nm, 216fg, resp) while particle concentration was not statistically different between RA patients and HC (0.89, 2.59 x1010/ml, resp). In 13 out of 28 RA patients TNFα (220 pg/ml) was detectable in pEVs by BBI whereas in HC TNFα was undetectable. Presence of TNFa on RA-pEVs was confirmed by FC. Preincubation of pEVs with anti-TNFα antibodies (etanercept) fully blocked TNFα detection. Unexpected, after preincubation with anti-TNFα Fab fragments (certolizumab pegol) TNFα was still detectable which suggested aspecific binding of the TNFa detection antibody. By ELISA IgM-RF was detectable on pEVs in 9 out of 13 RA patients. By preincubation with Protein-L coupled magnetic beads, to scavenge RF, TNFα levels on pEVs isolated from RF+ RA patients were reduced to background.

Conclusion: This study shows for the first time that IgM-RF is present on pEVs in a subpopulation of RA patients and this impedes with immunodetection of TNFα. To obtain conclusive evidence for the presence of TNFα other laboratory techniques are needed. However, the presence of RF on EVs could be important in the immunopathophysiology of RA by directing putative immunoregulatory and potentially inflammatory EVs to sites of immune-complex formation.

1: Keffer. EMBO J. (1991)

2: Zhang. J Immunol (2006)


Disclosure: O. J. Arntz, None; B. C. H. Pieters, None; R. Thurlings, None; P. M. van der Kraan, Contract research UCB, 2; F. van den Hoogen, None; F. A. J. van de Loo, None.

To cite this abstract in AMA style:

Arntz OJ, Pieters BCH, Thurlings R, van der Kraan PM, van den Hoogen F, van de Loo FAJ. The Presence of IgM Rheumatoid Factor Impede Immunodetection of Tnfa on Circulating Extracellular Vesicles Obtained from Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-presence-of-igm-rheumatoid-factor-impede-immunodetection-of-tnfa-on-circulating-extracellular-vesicles-obtained-from-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-presence-of-igm-rheumatoid-factor-impede-immunodetection-of-tnfa-on-circulating-extracellular-vesicles-obtained-from-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology